SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-18-277572
Filing Date
2018-09-19
Accepted
2018-09-19 16:02:16
Documents
7
Effectiveness Date
2018-09-19

Document Format Files

Seq Description Document Type Size
1 S-3ASR d619312ds3asr.htm S-3ASR 335877
2 EX-4.1 d619312dex41.htm EX-4.1 285311
3 EX-4.2 d619312dex42.htm EX-4.2 281074
4 EX-5.1 d619312dex51.htm EX-5.1 26381
5 EX-12.1 d619312dex121.htm EX-12.1 7803
6 EX-23.1 d619312dex231.htm EX-23.1 1657
7 EX-23.2 d619312dex232.htm EX-23.2 1536
  Complete submission text file 0001193125-18-277572.txt   940614
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-227427 | Film No.: 181077788
SIC: 2836 Biological Products, (No Diagnostic Substances)